Number needed to treat (NNT) to have an additional patient free from a severe or moderate/severe exacerbation: post-hoc analysis of SYGMA 1 in mild asthma

被引：2
|
作者：
Fitzgerald, Mark [1 ]
O'Byrne, Paul M. [2 ,3 ]
Bateman, Eric D. [4 ]
Barnes, Peter J. [5 ]
Zhong, Nanshan [6 ]
Alagappan, Vijay [7 ]
Whelan, Glenn [7 ]
Lamarca, Rosa [8 ]
Puu, Margareta [9 ]
Reddel, Helen K. [10 ]
机构：
[1] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC, Canada
[2] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada
[3] McMaster Univ, Dept Med, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ Cape Town, Div Pulmonol, Dept Med, Cape Town, South Africa
[5] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Sect, London, England
[6] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Peoples R China
[7] AstraZeneca, Gaithersburg, MD USA
[8] AstraZeneca, Barcelona, Spain
[9] AstraZeneca, Gothenburg, Sweden
[10] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Exacerbation;
D O I：
10.1183/13993003.congress-2019.PA3716
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3716
引用
收藏
页数：3
相关论文
共 39 条
  • [1] NUMBER NEEDED TO TREAT WITH AS-NEEDED BUDESONIDE/FORMOTEROL OR BUDESONIDE MAINTENANCE TO HAVE AN ADDITIONAL PATIENT FREE FROM A SEVERE OR MODERATE/SEVERE EXACERBATION: POST-HOC ANALYSIS OF SYGMA 1 IN MILD ASTHMA
    Reddel, H.
    O'Byrne, P.
    Bateman, D. E.
    Barnes, P.
    Zheng, J.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    Fitzgerald, J.
    [J]. RESPIROLOGY, 2020, 25 : 106 - 106
  • [2] Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma
    O'Byrne, Paul
    Fitzgerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zhong, Nanshan
    Keen, Christina
    Wang, Millie
    Lamarca, Rosa
    Puu, Margareta
    Reddel, Helen K.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zheng, Jinping
    Gustafson, Per
    Lamarca, Rosa
    Puu, Margareta
    Keen, Christina
    Alagappan, Vijay K. T.
    Reddel, Helen K.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 149 - 158
  • [4] Persistent Airflow Limitation and the Risk for Moderate-Severe Asthma Exacerbations: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies
    Singh, D.
    Virchow, J.
    Cononica, W.
    Vele, A.
    Georges, G.
    Papi, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] Efficacy of As-Needed Budesonide/Formoterol for Reducing Severe Exacerbations in Adolescents with Mild Asthma: Pooled Subgroup Analysis of the SYGMA 1 and 2 Trials
    O'Byrne, P.
    Bateman, E.
    FitzGerald, J. M.
    Barnes, P. J.
    Zhong, N.
    Alagappan, V. K. T.
    Ivanov, S.
    Whelan, G.
    Lamarca, R.
    Puu, M.
    Reddel, H. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
    Busse, William W.
    Wenzel, Sally E.
    Casale, Thomas B.
    FitzGerald, J. Mark
    Rice, Megan S.
    Daizadeh, Nadia
    Deniz, Yamo
    Patel, Naimish
    Harel, Sivan
    Rowe, Paul J.
    Graham, Neil M. H.
    O'Riordan, Thomas
    Pavord, Ian D.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1165 - 1173
  • [7] Identification of Patients with Uncontrolled, Moderate-to-Severe Asthma with High Sleep Disturbance and Efficacy of Dupilumab in This Subgroup: Post-Hoc Analysis from LIBERTY ASTHMA QUEST
    Maspero, J. F.
    Shafazand, S.
    Cole, J.
    Pavord, I. D.
    Busse, W. W.
    Msihid, J.
    Gall, R.
    Soler, X.
    Siddiqui, S.
    Khan, A.
    Gomez, L. De Prado
    Jacob-Nara, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] ALBUTEROL-BUDESONIDE RESCUE INHALER IN PATIENTS>=18 YEARS WITH MODERATE TO-SEVERE ASTHMA: POST-HOC ANALYSIS OF MANDALA
    Chipps, B.
    Papi, A.
    Beasley, R.
    Israel, E.
    Panettieri, R.
    Cappelletti, C.
    Dunsire, L.
    Trudo, F.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S5 - S6
  • [9] COST-PER-NUMBER NEEDED TO TREAT (NNT) ANALYSIS OF INFLIXIMAB COMPARED TO ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
    Morais, A. D.
    Pereira, M. L.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A214 - A214
  • [10] Efficacy of albuterol-budesonide asthma rescue inhaler in adults with moderate-to-severe asthma with exercise as a trigger: post-hoc sub-group analysis of MANDALA
    Israel, Elliot
    Chipps, Bradley
    Beasley, Richard
    Panettieri, R., Jr.
    Bardsley, Sam
    Cappelletti, Christy
    Dunsire, Lynn
    Gilbert, Ileen
    Harrison, Tim
    Trudo, Frank
    Papi, Alberto
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB98 - AB98
1234